Showing results (511-520 of 553) with videos related to
Sort By:
Pageof 56
Drugs in Context|August 14, 2020
Use of biologic agents and risk of tuberculosis in Brazil, a tuberculosis high-burden countryFernanda Gomes Gonçalves Chaer, Juliana Miranda de Lucena Valim, Rogério Castro Reis, et al.Drugs in Context|July 24, 2020
Urinary tract infections in the elderly: a review of disease characteristics and current treatment optionsLeocadio Rodriguez-MañasDrugs in Context|July 17, 2020
Experience with ospemifene in a patient with vulvovaginal atrophy and dyslipidemia: a case studySilvia Pilar González RodríguezDrugs in Context|July 17, 2020
Experience with ospemifene in patients with vulvar and vaginal atrophy and a history of breast cancer: case studiesMariella Lilue, Santiago Palacios, María Del Carmen Pingarrón SantofimiaDrugs in Context|August 4, 2020
Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosusAlexander Kc Leung, Tara McMillan, Andrea Human, et al.Drugs in Context|January 17, 2014
Probabilistic data linkage: a case study of comparative effectiveness in COPDChristopher M Blanchette, Mitch Dekoven, Ajita P De, et al.Drugs in Context|February 25, 2015
Adherence to risk evaluation and mitigation strategies (REMS) requirements for monthly testing of liver functionChristopher M Blanchette, Anthony P Nunes, Nancy D Lin, et al.Drugs in Context|June 27, 2020
Topical treatment of radiation-induced dermatitis: current issues and potential solutionsNicola Alessandro Iacovelli, Yvan Torrente, Adriana Ciuffreda, et al.Drugs in Context|October 15, 2021
Aducanumab: evidence from clinical trial data and controversiesRajesh R Tampi, Brent P Forester, Marc AgroninDrugs in Context|September 27, 2021
Transdermal buprenorphine for pain management in childrenGiorgio Attinà, Alberto Romano, Silvia Triarico, et al.Pageof 56